Case Report

Reserpine for the treatment of refractory mania

Ingrid Geeske Eloff, Willem Esterhuysen
South African Journal of Psychiatry | Vol 20, No 1 | a456 | DOI: https://doi.org/10.4102/sajpsychiatry.v20i1.456 | © 2014 Ingrid Geeske Eloff, Willem Esterhuysen | This work is licensed under CC Attribution 4.0
Submitted: 03 May 2013 | Published: 30 April 2014

About the author(s)

Ingrid Geeske Eloff, Department of Psychiatry, Elizabeth Donkin Hospital, Walter Sisulu University, Port Elizabeth, South Africa
Willem Esterhuysen, Department of Psychiatry, Elizabeth Donkin Hospital, Walter Sisulu University, Port Elizabeth, South Africa, South Africa

Full Text:

PDF (578KB)

Abstract

We report a case of refractory mania treated successfully with reserpine. The patient was a 26-year-old man with bipolar I disorder, who had recurrent hospital admissions for manic episodes that failed to respond to multiple mood stabilisers and antipsychotics. The patient also suffered from hypertension. His manic symptoms improved markedly with the addition of reserpine to the treatment regimen. Reserpine is a centrally acting antihypertensive with anti-adrenergic properties. It has been found to reduce the duration of a manic episode rapidly in a small group of studies. This proved to be the case with this patient. Reserpine used  in conjunction with other psychotropic medication may be considered in the treatment of refractory mania, but controlled trials are necessary to support our finding more generally.


Keywords

bipolar disorder type 1; mania; refractory mania; reserpine

Metrics

Total abstract views: 2859
Total article views: 1293

 

Crossref Citations

1. Challenges in defining treatment‐resistant mania in adults: A systematic review
Christina Gonzalez‐Torres, Benoit H. Mulsant, M. Ishrat Husain, Martin Alda, Robert C. Young, Abigail Ortiz
Bipolar Disorders  vol: 26  issue: 1  first page: 7  year: 2024  
doi: 10.1111/bdi.13383